Cytogenetic analysis of pediatric anaplastic large cell lymphoma

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 446-451

  Mussolin, Lara ^a   Pillon, Marta ^a   Bonato, Paola ^a   Leszl, Anna ^a   Franceschetto, Genny ^a   Di Meglio, Annamaria ^a   D'Amore, Emanuele S G ^a   Sainati, Laura ^a   Rosolen, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

ALCL; ALK; Child; Cytogenetics; Review

Indexed keywords

ADOLESCENT; ALK GENE; ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME 13; CHROMOSOME 15; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; KARYOTYPE; LARGE CELL LYMPHOMA; MALE; MONOSOMY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRISOMY; TRISOMY 7; ADULT; CHROMOSOME ABERRATION; COMPARATIVE STUDY; DIPLOIDY; GENE TRANSLOCATION; GENETICS;

ANAPLASTIC LYMPHOMA KINASE; P80(NPM ALK) PROTEIN; P80(NPM-ALK) PROTEIN; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; CHILD; CHROMOSOME ABERRATIONS; DIPLOIDY; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MONOSOMY; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; TRISOMY;

EID: 77955506951     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22550     Document Type: Article

References (21)

1. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238-1248.
2. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 1989;71:31-36.
3. Fujimoto J, Shiota M, Iwahara T, et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 1996;93:4181-4186.
4. Bai RY, Dieter P, Peschel C, et al. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 1998;18:6951-6961.
5. Lamant L, Dastugue N, Pulford K, et al. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999;93:3088-3095.
6. Hernandez L, Pinyol M, Hernandez S, et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood 1999;94:3265-3268.
7. Ma Z, Cools J, Marynen P, et al. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood 2000;95:2144-2149.
8. Touriol C, Greenland C, Lamant L, et al. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000;95:3204-3207.
9. Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood 2001;98:1209-1216.
10. Tort F, Pinyol M, Pulford K, et al. Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma. Lab Invest 2001;81:419-426.
11. Shaffer LG, Karger TN, Basel S, editors. ISCN an international system for human cytogenetic nomenclature. Basel: S. Karger AG; 2005.130 p.
12. Mussolin L, Pillon M, d'Amore ES, et al. Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma. Leukemia 2005;19:1643-1647.
13. Aamot HV, Torlakovic EE, Eide MB, et al. Non-Hodgkin lymphoma with t(14;18): Clonal evolution patterns and cytogeneticpathologic-clinical correlations. J Cancer Res Clin Oncol 2007;133:455-470.
14. Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 1999;25:123-133.
15. Hoglund M, Sehn L, Connors JM, et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004;39:195-204.
16. Heim S, Mitelman F. Cancer cytogenetics: Chromosomal and molecular genetic aberrations of tumor cells. New York: Wiley-Liss; 1995.
17. Fonseca R, Oken MM, Harrington D, et al. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia 2001;15:981-986.
18. Kaufmann H, Kromer E, Nosslinger T, et al. Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma. Eur J Haematol 2003;71:179-183.
19. Wada M, Okamura T, Okada M, et al. Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma. Leukemia 1999;13:792-798.
20. Tilly H, Bastard C, Delastre T, et al. Cytogenetic studies in untreated Hodgkin's disease. Blood 1991;77:1298-1304.
21. Harris RL, Harrison CJ, Martineau M, et al. Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia? Cancer Genet Cytogenet 2004;148:159-162.